The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-(2-(3-Fluorophenoxy)acetyl)piperazin-1-yl)benzoic acid ID: ALA4539864
PubChem CID: 155549925
Max Phase: Preclinical
Molecular Formula: C19H19FN2O4
Molecular Weight: 358.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1ccc(N2CCN(C(=O)COc3cccc(F)c3)CC2)cc1
Standard InChI: InChI=1S/C19H19FN2O4/c20-15-2-1-3-17(12-15)26-13-18(23)22-10-8-21(9-11-22)16-6-4-14(5-7-16)19(24)25/h1-7,12H,8-11,13H2,(H,24,25)
Standard InChI Key: ZFEXGUVIWYAMFB-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
24.9899 -20.3289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9888 -21.1562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7036 -21.5691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4201 -21.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4171 -20.3252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7018 -19.9161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1351 -21.5672 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1321 -22.3923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8431 -22.8036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5594 -22.3935 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.5601 -21.5675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8445 -21.1517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2729 -22.8075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2711 -23.6325 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9883 -22.3966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7018 -22.8107 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4172 -22.3998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1297 -22.8176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8447 -22.4073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8469 -21.5815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1283 -21.1676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4164 -21.5802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2754 -19.9166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2752 -19.0916 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.5610 -20.3293 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.5580 -22.8217 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
10 13 1 0
13 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
1 23 1 0
23 24 2 0
23 25 1 0
19 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.37Molecular Weight (Monoisotopic): 358.1329AlogP: 2.25#Rotatable Bonds: 5Polar Surface Area: 70.08Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.71CX Basic pKa: 1.40CX LogP: 2.47CX LogD: -0.16Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.89Np Likeness Score: -1.65
References 1. Ragle LE, Palanisamy DJ, Joe MJ, Stein RS, Norman DD, Tigyi G, Baker DL, Parrill AL.. (2016) Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition., 24 (19): [PMID:27544588 ] [10.1016/j.bmc.2016.08.004 ]